Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of Decompensated Hepatitis C Virus-Related Cirrhotic Patients Treated With Peginterferon Alfa-2b and Ribavirin: Results of a Controlled Study

NCT00301509 is registered in ClinicalTrials.gov with Casa Sollievo della Sofferenza IRCCS as lead sponsor.

NCT NCT00301509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00301509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of Decompensated Hepatitis C Virus-Related Cirrhotic Patients Treated With Peginterferon Alfa-2b and Ribavirin: Results of a Controlled Study
Lead sponsor
Casa Sollievo della Sofferenza IRCCS
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2002
Completion date
December 31, 2005
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, experimental